{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:56:20Z","timestamp":1758268580613,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:00:00Z","timestamp":1444780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10620-015-3911-6","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T05:52:35Z","timestamp":1444801955000},"page":"3552-3557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas"],"prefix":"10.1007","volume":"60","author":[{"given":"Channa R.","family":"Jayasekera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan B.","family":"Perumpail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avin","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-8586","authenticated-orcid":false,"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"key":"3911_CR1","volume-title":"A national strategy for prevention and control of hepatitis B and C","author":"Hepatitis and Liver Cancer","year":"2010","unstructured":"Hepatitis and Liver Cancer. A national strategy for prevention and control of hepatitis B and C. Washington, DC: Institute of Medicine; 2010."},{"key":"3911_CR2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","volume":"160","author":"MM Denniston","year":"2014","unstructured":"Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann. Intern. Med. 2014;160:293\u2013300.","journal-title":"Ann. Intern. Med."},{"key":"3911_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cld.376","volume":"4","author":"N Reau","year":"2014","unstructured":"Reau N. HCV testing and linkage to care: expanding access: HCV testing and linkage to care. Clin. Liver Dis. 2014;4:31\u201334.","journal-title":"Clin. Liver Dis."},{"key":"3911_CR4","doi-asserted-by":"crossref","unstructured":"Kredo T, Adeniyi FB, Bateganya M, Pienaar ED. Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy. In: The Cochrane Collaboration, ed. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester. doi: 10.1002\/14651858.CD007331.pub3 . Accessed 12 Dec 2014.","DOI":"10.1002\/14651858.CD007331.pub3"},{"key":"3911_CR5","unstructured":"American Association for the Study of Liver Diseases, Infectious Diseases Society of America. Recommendations for testing, managing, and treating hepatitis C. http:\/\/www.hcvguidelines.org\/printpdf\/92 . Accessed 5 Dec 2014."},{"key":"3911_CR6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/hep.27775","volume":"62","author":"VV Chirikov","year":"2015","unstructured":"Chirikov VV, Shaya FT, Howell CD. Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in Medicare patients. Hepatology. 2015;62:68\u201378.","journal-title":"Hepatology."},{"key":"3911_CR7","first-page":"453","volume":"64","author":"JE Zibbell","year":"2015","unstructured":"Zibbell JE, Iqbal K, Patel RC, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged\u00a0\u2264\u00a030\u00a0years\u2014Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012. MMWR Morb. Mortal. Wkly. Rep. 2015;64:453\u2013458.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"3911_CR8","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.23220","volume":"50","author":"ML Volk","year":"2009","unstructured":"Volk ML, Tocco R, Saini S, Lok ASF. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology. 2009;50:1750\u20131755.","journal-title":"Hepatology"},{"key":"3911_CR9","doi-asserted-by":"crossref","first-page":"e101554","DOI":"10.1371\/journal.pone.0101554","volume":"9","author":"BR Yehia","year":"2014","unstructured":"Yehia BR, Schranz AJ, Umscheid CA, Lo Re V. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS ONE. 2014;9:e101554.","journal-title":"PLoS ONE"},{"key":"3911_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/M14-1336","volume":"162","author":"J Chhatwal","year":"2015","unstructured":"Chhatwal J, Kanwal F, Roberts MS, Dunn MA. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann. Intern. Med. 2015;162:397.","journal-title":"Ann. Intern. Med."},{"key":"3911_CR11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/M14-1152","volume":"162","author":"M Najafzadeh","year":"2015","unstructured":"Najafzadeh M, Andersson K, Shrank WH, et al. Cost-effectiveness of novel regimens for the treatment of hepatitis C Virus. Ann. Intern. Med. 2015;162:407.","journal-title":"Ann. Intern. Med."},{"key":"3911_CR12","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","volume":"364","author":"S Arora","year":"2011","unstructured":"Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N. Engl. J. Med. 2011;364:2199\u20132207.","journal-title":"N. Engl. J. Med."},{"key":"3911_CR13","doi-asserted-by":"crossref","first-page":"e84826","DOI":"10.1371\/journal.pone.0084826","volume":"8","author":"C Rongey","year":"2013","unstructured":"Rongey C, Shen H, Hamilton N, Backus LI, Asch SM, Knight S. Impact of rural residence and health system structure on quality of liver care. PLoS ONE. 2013;8:e84826.","journal-title":"PLoS ONE"},{"key":"3911_CR14","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(14)61036-9","volume":"384","author":"E Lawitz","year":"2014","unstructured":"Lawitz E, Sulkowski MS, Ghalib R, et al. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. The Lancet. 2014;384:1756\u20131765.","journal-title":"The Lancet"},{"key":"3911_CR15","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","volume":"368","author":"E Lawitz","year":"2013","unstructured":"Lawitz E, Mangia A, Wyles D, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N. Engl. J. Med. 2013;368:1878\u20131887.","journal-title":"N. Engl. J. Med."},{"key":"3911_CR16","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa1316145","volume":"370","author":"S Zeuzem","year":"2014","unstructured":"Zeuzem S, Dusheiko GM, Salupere R, et al. Sofosbuvir and ribavirin in HCV genotypes 2 and 3. N. Engl. J. Med. 2014;370:1993\u20132001.","journal-title":"N. Engl. J. Med."},{"key":"3911_CR17","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","volume":"368","author":"IM Jacobson","year":"2013","unstructured":"Jacobson IM, Gordon SC, Kowdley KV, et al. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N. Engl. J. Med. 2013;368:1867\u20131877.","journal-title":"N. Engl. J. Med."},{"key":"3911_CR18","unstructured":"Jensen DM, O\u2019Leary J, Pockros P, et al. Safety and efficacy of sofosbuvir-containing regimens for hepatitis C: Real-world experience in a diverse, longitudinal observational cohort (HCV-TARGET). The Liver Meeting: American Association for the Study of Liver Diseases, Boston, MA. Abstract 45: 2014."},{"key":"3911_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/apt.13300","volume":"42","author":"LI Backus","year":"2015","unstructured":"Backus LI, Belperio PS, Shahoumian TA, Loomis TP, Mole LA. Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans. Aliment. Pharmacol. Ther. 2015;42:559\u2013573.","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3911-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3911-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3911-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:49:56Z","timestamp":1559231396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3911-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,14]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["3911"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3911-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2015,10,14]]}}}